September 21, 20231:32 PM ET By Sydney Lupkin Ozempic, approved by the Food and Drug Administration for Type 2 diabetes, is racking up blockbuster sales because many people are taking it to lose weight. As more people try it, reports to the FDA about possible side effects are rising.Nearly three months into taking Ozempic for...
Tag: <span>Ozempic</span>
Post
List prices for Ozempic, Wegovy far higher in the US than in peer nations
Aug 18, 2023 03:10pm While interest in them for off-label prescribing is grabbing headlines, the U.S. also has the highest rates of obesity in the world, meaning potential use would be elevated even if the drugs weren’t currently trendy. (Photo illustration by Mario Tama/Getty Images)It’s not a secret that Americans pay far more than people...
Post
FDA adds warning to Ozempic label about risk for blocked intestines
by Cara Murez FDA adds warning to ozempic label about risk for blocked intestinesOzempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines. The U.S. Food and Drug Administration recently made the label update for the drug made...
Post
Ozempic, the ‘miracle drug,’ and the harmful idea of a future without fat
Michael Orsini, Professor, Institute of Feminist and Gender Studies | School of Political Studies, L’Université d’Ottawa/University of Ottawa and Fady Shanouda, Assistant Professor, Critical Disability Studies, Carleton University. Following news of Ozempic’s ability to help its users lose weight, it did not take long for fat-haters to surface. (Justin Katigbak/Disabled And Here) The headlines squeal with...
Post
Lawsuit against makers of Ozempic, Mounjaro claims meds caused ‘stomach paralysis’
by Cara Murez A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems. The lawsuit seeks “very significant” but unspecified compensation from the makers of both Ozempic and Mounjaro, said attorney Paul Pennock of the...
Post
Beyond Ozempic: New Obesity Drugs Could Be Cheaper and Even More Effective
By Saima Sidik, Nature magazine on July 5, 2023 Coloured scanning electron micrograph (SEM) of a sample of fat tissue, showing fat cells (adipocytes, red yellow) surrounded by fine strands of supportive connective tissue. The lipid-storage cells called adipocytes enlarge during the development of obesity. Credit: Steve Gschmeissner/Scence Photo Library/Getty Images Two new drugs for treating obesity are on course to become...
Post
An Ozempic-like drug might protect against the loss of dopaminergic neurons in Parkinson’s disease
by Eric W. Dolan June 26, 2023 in Mental Health [Subscribe to PsyPost Premium to enjoy an ad-free experience! Click here to sign up.] New research suggests that drugs used to treat insulin resistance could potentially help in treating neurodegenerative disorders like Parkinson’s disease. The study found that semaglutide, a compound found in medications like...
Post
Why Some People Are Claiming Life on Ozempic Is ‘Miserable’
While drugs like Ozempic and Wegovy can help people lose weight, they can also alter the way food tastes and may even impact your ability to derive pleasure from activities you enjoy. Catherine Falls Commercial/Getty Images The potential to make life boring and miserable may be an unwelcome side effect of drugs like Ozempic and...
Post
TikTok users are calling berberine ‘nature’s Ozempic’ – but is it a fad?
Berberine comes from the root and bark of several plants and has been used in China as a medicinal herb since ancient times. Photograph: DimaSobko/Getty Images/iStockphotoUS news The supplement has gained popularity but physicians and dietitians caution long-term effects are unclear Eric Berger Sun 11 Jun 2023 08.00 EDT When Savannah Crosby started posting videos on TikTok about...
Post
Akero’s NASH drug combined with Ozempic cut liver fat in small study
By Elaine Chen June 5, 2023 ADOBE GLP-1s, a class of drugs including Ozempic and Wegovy that have become widely popular for treating obesity and diabetes, are also being studied for NASH, a form of fatty liver disease. But a new small study suggests GLP-1s may not dominate the disease area as they have others. Akero Therapeutics tested...